CEACAM1 and metabolic dysfunction-associated steatohepatitis: In CEACAM1 null mice, the absence of CEACAM1 led to an inability to clear insulin, leading to hyperinsulinemia followed by insulin resistance, obesity, and non-alcoholic steatohepatitis [120].